r.jhannsdttir
TL3 Regular · Parma, IT
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 4 January 2025 · last posted 3d · groups: journal-club
156 posts, newest first. Showing up to 150.
-
Programming during a large energy deficit Replied, post #49 · Nutrition & Training › Resistance training · 25 Jul 2026 · 17 likes Programming during a large energy looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 14 likes Second this, and I would have said it less carefully.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #92 · Nutrition & Training › Protein & intake · 22 Jul 2026 · 4 likes Saving this. It is the version I will quote when the question comes round again.
-
How shortages have affected compounding permissions Replied, post #58 · Access › Shortages · 21 Jul 2026 · 1 like Nothing to add, except that this is the answer I would give if asked.
-
What a certificate commits its issuer to Replied, post #45 · Analytics › COA interpretation · 17 Jul 2026 · 23 likes Answering the question post #41 raises rather than the one it answers. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #85 · Practice › Storage & stability · 9 Jul 2026 · 18 likes Trying to state the peptide position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Revisiting: What pooling buys you and what it destroys Replied, post #84 · Evidence › Meta-analyses · 9 Jul 2026 · 0 likes Where the pooling buys discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Why side effects reset at each escalation and that is not a failure Replied, post #4 · Practice › Side effects · 7 Jul 2026 · 33 likes Worth separating two things that post #2 runs together. Effects that improve with time and effects that improve with dose reduction are different findings. Working out…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #34 · Start Here › Welcome · 6 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #49 · Analytics › Home & field testing · 3 Jul 2026 · 0 likes Worth separating two things that post #47 runs together. The version of consumer-accessible tests that I was taught turned out to be a teaching simplification. Useful,…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #62 · Evidence › Journal club · 29 Jun 2026 · 13 likes Post #58 put the caveat in the right place and I want to underline it. Distinguishing three things in the SURMOUNT-1 discussion that keep getting used interchangeably:…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #48 · Sourcing › Independent verification · 28 Jun 2026 · 11 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
[2026 update] Journal club: what we got wrong in an earlier session Replied, post #3 · Evidence › Journal club · 26 Jun 2026 · 1 like Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Second pass at: Programming during a large energy deficit Replied, post #36 · Nutrition & Training › Resistance training · 20 Jun 2026 · 11 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor.
-
Spreadsheets: an appreciation — what changed since Replied, post #73 · Lounge › Off topic · 17 Jun 2026 · 0 likes Spreadsheets is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
GLP-1 receptor distribution: central and peripheral Replied, post #68 · Pharmacology › Receptor biology · 12 Jun 2026 · 0 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Racemisation and why it is invisible to a mass measurement Replied, post #38 · Analytics › Impurities & related substances · 10 Jun 2026 · 0 likes Narrowing post #35, because the general version has more than one answer. Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks.…
-
What to include when your question involves a chromatogram — one year on Replied, post #30 · Start Here › How to Ask · 8 Jun 2026 · 14 likes Post #26 and I disagree about the size of the effect, not about the direction. Context that matters: compound, how long in, current dose, relevant history. Context that…
-
Private prescribing in the UK: what is actually involved Replied, post #33 · Regional › UK & Ireland · 8 Jun 2026 · 7 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #37 · Analytics › HPLC & UHPLC · 4 Jun 2026 · 4 likes Post #35 is the version of this I will quote in future. One addition. Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre…
-
Official shortage notices and what they authorise Replied, post #85 · Access › Shortages · 3 Jun 2026 · 16 likes Post #83 is the version of this I will quote in future. One addition. I read the earlier replies on official shortage notices twice before writing this, because I had…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #32 · Clinical › Special populations · 30 May 2026 · 0 likes A definition problem is doing most of the work in this bariatric surgery history discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
-
Preservatives: function, testing, and limits — one year on Replied, post #20 · Pharmacology › Formulation chemistry · 29 May 2026 · 11 likes Speaking only to Preservatives as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Historical amylin analogues and what happened to them Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 23 May 2026 · 15 likes Post #9 describes the usual case. This is about the unusual one. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some…
-
An 18-month record including the parts that went badly Replied, post #18 · Outcomes › Progress reports · 17 May 2026 · 23 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Spreadsheets: an appreciation — what changed since Replied, post #42 · Lounge › Off topic · 14 May 2026 · 7 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. It is a small point…
-
Temperature indicator cards: worth asking for? Replied, post #7 · Sourcing › Logistics · 10 May 2026 · 15 likes Delivery to an address where somebody is present is worth more for cold-chain material than any packing decision available to the supplier. The step people skip is the…
-
Request: show the solution author in the topic list — what changed since Replied, post #60 · Meta › Feature requests · 3 May 2026 · 8 likes Post #58 put the caveat in the right place and I want to underline it. I would use that constantly. The objection is presumably that it is data the site then has to…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #27 · Clinical › Bloodwork · 30 Apr 2026 · 6 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #2 · Analytics › COA interpretation · 27 Apr 2026 · 0 likes The opening post answers the question as asked. The question underneath it is different. Field-by-field walk through a certificate came up in a thread eighteen months…
-
Private prescribing in the UK: what is actually involved Replied, post #4 · Regional › UK & Ireland · 25 Apr 2026 · 2 likes Everything in the opening post holds. The case it does not cover is the one I have. Availability through a private route and availability through the public system are…
-
[2026 update] What a purity-only report leaves out Replied, post #99 · Sourcing › Independent verification · 21 Apr 2026 · 15 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. It reads as pedantry until the day it does not.
-
Validating a calculator against hand arithmetic Replied, post #19 · Data & Tools › Calculators · 19 Apr 2026 · 11 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #33 · Evidence › Journal club · 17 Apr 2026 · 2 likes Two claims get bundled together under indirect comparison and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Reading a home test result without over-claiming Replied, post #13 · Analytics › Home & field testing · 15 Apr 2026 · 33 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #10 · Practice › Reconstitution · 13 Apr 2026 · 17 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That has held…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #13 · Devices › Syringes & needles · 12 Apr 2026 · 0 likes Since 0.3 ml versus 0.5 ml keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Coming back to: Training through a dose escalation week Replied, post #73 · Nutrition & Training › Resistance training · 7 Apr 2026 · 0 likes Where I part company with post #69, and it is a narrow parting. Frequency matters less than consistency and progression. Two sessions a week done every week beats four…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #8 · Devices › Syringes & needles · 4 Apr 2026 · 3 likes Where I part company with post #4, and it is a narrow parting. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #57 · Data & Tools › Calculators · 3 Apr 2026 · 1 like Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #42 · Practice › Interactions · 3 Apr 2026 · 24 likes Widely repeated interaction claim is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
Oral versus injected administration claims for BPC-157 Replied, post #22 · Compounds › Repair & healing peptides · 16 Mar 2026 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. On oral versus injected administration claims the community has more anecdote than…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #12 · Compounds › Repair & healing peptides · 8 Mar 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. What would change the position on repair peptides: adequately powered, published,…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 6 Mar 2026 · 8 likes Post #43 answers the question as asked. The question underneath it is different. Native amylin has awkward physical properties — it aggregates readily, which is why a…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #19 · Evidence › Trials · 4 Mar 2026 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #6 · Analytics › Mass spectrometry · 2 Mar 2026 · 14 likes Everything in post #2 holds. The case it does not cover is the one I have. Resolution and mass accuracy are different specifications. An instrument can resolve two…
-
Measurement error in a self-reported exposure Replied, post #65 · Evidence › Study critique · 25 Feb 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Choosing which test to pay for, given a fixed budget Replied, post #4 · Sourcing › Independent verification · 23 Feb 2026 · 0 likes Answering the question the opening post raises rather than the one it answers. The record shows what was measured. Everything beyond that is inference and this site…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #15 · Compounds › Secretagogues & GH axis · 21 Feb 2026 · 8 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
A single out-of-range value on an otherwise normal panel Replied, post #16 · Clinical › Bloodwork · 21 Feb 2026 · 29 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. I have left out the parts I could not verify.
-
Research-use-only labelling: what it means and what it does not Replied, post #105 · Sourcing › Regulatory · 19 Feb 2026 · 7 likes Practical experience of research-use-only labelling, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 17 Feb 2026 · 19 likes Narrowing post #10, because the general version has more than one answer. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #54 · Outcomes › Body composition · 15 Feb 2026 · 0 likes Second this, and I would have said it less carefully.
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #5 · Sourcing › Logistics · 14 Feb 2026 · 31 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Guidelines revision: what changed and why — one year on Replied, post #70 · Meta › Announcements · 13 Feb 2026 · 0 likes On post #66 — agreed on the reasoning, with one qualification. Guidelines revision is worth one more sentence than it usually gets, and the sentence is the one about…
-
Journal club: LEADER as the historical anchor Replied, post #33 · Evidence › Journal club · 10 Feb 2026 · 17 likes Narrowing post #31, because the general version has more than one answer. Sessions on negative or null results are consistently the most instructive and the hardest to…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #10 · Analytics › Impurities & related substances · 9 Feb 2026 · 5 likes Post #7 is the version of this I will quote in future. One addition. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #34 · Evidence › Study critique · 7 Feb 2026 · 17 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #11 · Clinical › Comorbidities · 14 Jan 2026 · 0 likes A note on how gastro-oesophageal reflux gets discussed rather than on gastro-oesophageal reflux itself: the confident posts get the replies and the careful ones get…
-
Follow-up: Search filters: what is missing Replied, post #13 · Meta › Site feedback · 12 Jan 2026 · 28 likes That is consistent with mine, for whatever one more account is worth.
-
A partial dose because the pen emptied mid-injection Replied, post #99 · Practice › Administration · 10 Jan 2026 · 0 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
What a stability-indicating method is and how you demonstrate one Replied, post #2 · Analytics › Method validation · 6 Jan 2026 · 0 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Linearity across the working range is a routine demonstration and it…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #10 · Documentation › Wiki requests · 24 Dec 2025 · 0 likes Post #8 is right about the mechanism and I think understates the practical bit. The most useful requests here identify a specific confusion that keeps recurring rather…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #36 · Compounds › Other compounds · 19 Dec 2025 · 3 likes Adding a null result on AOD-9604. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Tracking a preprint to publication: a worked example Replied, post #141 · Evidence › Preprints · 14 Dec 2025 · 10 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong.
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #6 · Practice › Storage & stability · 29 Nov 2025 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #20 · Devices › Pens & autoinjectors · 23 Nov 2025 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Air in a cartridge behaves differently from air in a syringe because the mechanism…
-
Pen dose counters: what a click does and does not guarantee Replied, post #97 · Devices › Pens & autoinjectors · 19 Nov 2025 · 14 likes Priming exists because the needle and the cartridge path contain air after a needle change. Skipping it means the first fraction of the dose is not liquid.
-
Managing an unplanned gap in supply — what changed since Replied, post #115 · Access › Shortages · 13 Nov 2025 · 0 likes Managing an unplanned gap: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Titles that describe the question, not the situation Replied, post #145 · Start Here › How to Ask · 10 Nov 2025 · 0 likes Post #142 is the version of this I will quote in future. One addition. The thing about titles that took me longest to accept is that a plausible mechanism is not…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #7 · Clinical › Bloodwork · 1 Nov 2025 · 0 likes Filing a mild objection to the consensus on reference intervals. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #28 · Sourcing › Vendor reports · 25 Oct 2025 · 14 likes Post #27 is the version of this I will quote in future. One addition. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #54 · Compounds › Tirzepatide · 24 Oct 2025 · 1 like Post #51 is the version of this I will quote in future. One addition. Dual agonism is well covered in the tag pages, and the older discussions are better than the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #53 · Compounds › Tirzepatide · 21 Oct 2025 · 19 likes Post #49 put the caveat in the right place and I want to underline it. An observation about SURMOUNT-4 that I cannot explain and am posting anyway, on the principle…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #44 · Compounds › Tirzepatide · 21 Oct 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #118 · Practice › Administration · 19 Oct 2025 · 5 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Sleep tracking data and its considerable limitations Replied, post #31 · Wellbeing › Sleep · 19 Oct 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Oral semaglutide bioavailability and its variability between people Replied, post #9 · Compounds › Oral incretins · 13 Oct 2025 · 0 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #5 · Devices › Pens & autoinjectors · 11 Oct 2025 · 30 likes Picking up post #2: that is the part I would want checked first. The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #2 · Safety › Adverse events · 6 Oct 2025 · 19 likes Where I part company with the opening post, and it is a narrow parting. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #61 · Evidence › Preprints · 30 Sep 2025 · 6 likes Post #59 describes the usual case. This is about the unusual one. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Reading an interaction checker output critically Replied, post #11 · Practice › Interactions · 26 Sep 2025 · 11 likes On post #7 — agreed on the reasoning, with one qualification. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #38 · Evidence › Journal club · 19 Sep 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
High-resolution MS on aggregates and what it can see Replied, post #67 · Analytics › Mass spectrometry · 13 Sep 2025 · 0 likes Narrowing post #66, because the general version has more than one answer. The honest summary of what a mass result buys you: it narrows the field of what the material…
-
Payment method and the leverage it gives you, ranked Replied, post #8 · Sourcing › Payments · 13 Sep 2025 · 21 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #77 · Data & Tools › Datasets · 9 Sep 2025 · 7 likes This follows post #74 rather than contradicting it. The question underneath Aggregated purity results across four is usually "how would I tell?" rather than "what is…
-
Temperature loggers worth the money Replied, post #27 · Devices › Cold chain · 7 Sep 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Specification in the result column: why that is a meaningful error Replied, post #39 · Analytics › COA interpretation · 3 Sep 2025 · 7 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #38 · Analytics › COA interpretation · 28 Aug 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Column chemistry choices for a 40-residue peptide Replied, post #19 · Analytics › HPLC & UHPLC · 23 Aug 2025 · 0 likes That is a fair summary of where the discussion has got to.
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #16 · Practice › Reconstitution · 19 Aug 2025 · 20 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #53 · Compounds › Retatrutide · 18 Aug 2025 · 2 likes Post #49 and I disagree about the size of the effect, not about the direction. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
A ten-fold dose error caught before injection — one year on Replied, post #121 · Devices › Syringes & needles · 4 Aug 2025 · 8 likes Answering the question post #117 raises rather than the one it answers. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
How to research a compound with no human data without deceiving yourself Replied, post #92 · Compounds › Other compounds · 3 Aug 2025 · 24 likes Marking my place. If it changes for me I will come back and say so.
-
How to research a compound with no human data without deceiving yourself Replied, post #73 · Compounds › Other compounds · 2 Aug 2025 · 0 likes Everything in post #70 holds. The case it does not cover is the one I have. Answering the research a compound question as asked, then the question I think is meant. As…
-
When to stop reading forums, including this one Replied, post #11 · Wellbeing › Mental health · 2 Aug 2025 · 4 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well.
-
A payment that went through twice: how it was resolved Started this topic · Sourcing › Payments · 30 Jul 2025 · 2 likes A payment that went through twice: how it was resolved Writing it up because I had to work it out twice and would rather nobody else did. A payments question, with the…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #37 · Analytics › Mass spectrometry · 30 Jul 2025 · 17 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. A…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 26 likes Published human data on cagrilintide alone is thinner than on the combination, which is the reverse of what most people assume from how it is discussed here. I would…
-
A field-by-field walk through a certificate of analysis Replied, post #63 · Analytics › COA interpretation · 16 Jul 2025 · 0 likes Narrowing post #62, because the general version has more than one answer. On field-by-field walk through a certificate, the part that usually goes wrong is that the…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #25 · Practice › Reconstitution · 14 Jul 2025 · 0 likes Post #24 is right about the mechanism and I think understates the practical bit. An observation about decimal-point error that I cannot explain and am posting anyway,…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #13 · Compounds › Tirzepatide · 10 Jul 2025 · 14 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #86 · Wellbeing › Mental health · 9 Jul 2025 · 6 likes Practical answer on history of disordered eating, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #125 · Clinical › Comorbidities · 26 Jun 2025 · 9 likes An update on my earlier obstructive sleep apnoea post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
About the Semaglutide category Replied, post #3 · Compounds › Semaglutide · 24 Jun 2025 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
EU-wide position versus national implementation Replied, post #13 · Regional › European Union · 24 Jun 2025 · 0 likes Post #10 is the version of this I will quote in future. One addition. Anyone quoting an eligibility threshold should cite the national document, because thresholds…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #39 · Compounds › Semaglutide · 23 Jun 2025 · 0 likes Adding the measurement that post #36 says would settle it. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #141 · Practice › Reconstitution · 21 Jun 2025 · 17 likes Where I part company with post #140, and it is a narrow parting. If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #29 · Sourcing › Regulatory · 19 Jun 2025 · 18 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #139 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 2 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Follow-up: Requesting a page: what makes a good request Replied, post #49 · Documentation › Wiki requests · 15 Jun 2025 · 0 likes A page that would need to be rewritten every quarter is usually better as a topic with a good marked solution.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #44 · Regional › UK & Ireland · 10 Jun 2025 · 9 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences. Not disagreeing with…
-
Coming back to: When "no data" is the complete and final answer Replied, post #7 · Compounds › Other compounds · 6 Jun 2025 · 0 likes Answering the question post #5 raises rather than the one it answers. When "no data" is the complete and final answer: if there is no published human data on a…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #35 · Compounds › Oral incretins · 21 May 2025 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Forced degradation studies: designing one that is informative — does this still hold? Started this topic · Analytics › Method validation · 19 May 2025 · 48 likes The question in the title: Forced degradation studies: designing one that is informative — does this still hold? I will give what I have already checked below so nobody…
-
Antibiotics and a course of something with delayed emptying Replied, post #36 · Practice › Interactions · 7 May 2025 · 16 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Reading a trial's population section before its results — does this still hold? Replied, post #76 · Evidence › Trials · 7 May 2025 · 0 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. Composite endpoints should be read component by component. A composite driven…
-
Adjudicated events and why the definition matters — the long version Replied, post #117 · Evidence › Trials · 25 Apr 2025 · 0 likes On Adjudicated events I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Reading an MS report that only gives you a single number Replied, post #60 · Analytics › Mass spectrometry · 23 Apr 2025 · 23 likes Post #59 is the version of this I will quote in future. One addition. Resolution and mass accuracy are different specifications. An instrument can resolve two species…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #31 · Regional › UK & Ireland · 20 Apr 2025 · 9 likes Filing a mild objection to the consensus on Pharmacy supply. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Requesting a page: what makes a good request Replied, post #54 · Documentation › Wiki requests · 12 Apr 2025 · 6 likes If a request is declined, the reasoning is written down, and it is worth reading because it usually describes a better version of the same idea.
-
A certificate whose chromatogram axes do not match its stated method Replied, post #8 · Sourcing › Red flags · 7 Apr 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Testimonials without a lot, a date, a method or a service are not evidence and are not a red…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #16 · Sourcing › Vendor reports · 23 Mar 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #65 · Wellbeing › Mental health · 23 Mar 2025 · 12 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Transit times by route, from a logged dataset — the long version Replied, post #72 · Sourcing › Logistics · 19 Mar 2025 · 17 likes Reading rather than answering, but this is the post I would point somebody at.
-
Maintainer handover: how it works Replied, post #55 · Meta › Wiki maintenance · 17 Mar 2025 · 3 likes Answering the question post #51 raises rather than the one it answers. I changed my mind about maintainer handover after someone here asked me for the source and I…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #8 · Clinical › Bloodwork · 7 Mar 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Criticising the method without criticising the authors Replied, post #45 · Evidence › Study critique · 7 Mar 2025 · 0 likes Everything in post #43 holds. The case it does not cover is the one I have. A criticism that would apply equally to every trial in the field is worth stating once and…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #136 · Sourcing › Regulatory · 5 Mar 2025 · 6 likes The arithmetic in post #133 is right; the assumption feeding it is the part to check. An indication approved for one age range does not extend to another, and…
-
Consistent declarations and why they matter more than clever ones Replied, post #108 · Sourcing › Logistics · 1 Mar 2025 · 31 likes Everything in post #104 holds. The case it does not cover is the one I have. I think the consistent declarations question is answerable and has not been answered, which…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #25 · Practice › Interactions · 23 Feb 2025 · 28 likes No disagreement from me. Posting only so the question does not look ignored.
-
A supplier that answers analytical questions with restated claims Replied, post #27 · Sourcing › Red flags · 20 Feb 2025 · 10 likes Adding the measurement that post #24 says would settle it. Distinguishing three things in the supplier discussion that keep getting used interchangeably: the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #130 · Evidence › Journal club · 17 Feb 2025 · 1 like SURPASS-2 was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
What we do not know about retatrutide, listed explicitly Replied, post #90 · Compounds › Retatrutide · 10 Feb 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Canadian access and provincial variation Replied, post #11 · Regional › North America · 22 Jan 2025 · 27 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #113 · Access › Insurance & coverage · 10 Jan 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #17 · Practice › Interactions · 26 Dec 2024 · 12 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Fibre intake when total intake falls, and the constipation link Replied, post #9 · Nutrition & Training › Protein & intake · 21 Dec 2024 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #80 · Access › Insurance & coverage · 21 Dec 2024 · 11 likes Everything in post #77 holds. The case it does not cover is the one I have. The documentation on Step therapy requirements is better than this thread and I say that as…
-
Coming back to: When to suspect the method rather than the sample Replied, post #106 · Analytics › Method validation · 20 Dec 2024 · 0 likes Post #104 and I disagree about the size of the effect, not about the direction. A stability-indicating method is one demonstrated to resolve the analyte from its…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #32 · Practice › Side effects · 28 Nov 2024 · 26 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #62 · Compounds › Tirzepatide · 22 Nov 2024 · 0 likes This follows post #59 rather than contradicting it. Adding a reference point for SURPASS-2. Mine is a single case, collected without controls, and I am posting the…
-
Fixed versus detachable needles: the trade-offs Replied, post #14 · Devices › Syringes & needles · 22 Nov 2024 · 29 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #30 · Compounds › Semaglutide · 17 Nov 2024 · 1 like On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Time to steady state after a dose increase Replied, post #131 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 23 likes Post #128 is right about the mechanism and I think understates the practical bit. Loading doses are not used in this class and the pharmacokinetic reason is…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #68 · Clinical › Comorbidities · 20 Oct 2024 · 9 likes On post #64 — agreed on the reasoning, with one qualification. A methods point on Hypertension improvement rather than a substantive one: if the comparison is not like…
-
Progressive overload when the scale is falling — one year on Replied, post #137 · Nutrition & Training › Resistance training · 8 Oct 2024 · 2 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose.
-
Gallbladder disease risk with rapid weight loss Replied, post #17 · Clinical › Comorbidities · 8 Oct 2024 · 33 likes Where the gallbladder disease risk discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Food noise reducing and the disorientation that can follow Replied, post #11 · Wellbeing › Mental health · 23 Sep 2024 · 0 likes An observation about food noise that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #59 · Clinical › Prescriber conversations · 17 Sep 2024 · 8 likes Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable.